Published July 25, 2017 This content is archived.
A story on CNBC about rising rates of gonorrhea and concerns that a strain may emerge that is completely resistant to all known antibiotics reports that people who received a vaccine developed to control a meningitis outbreak were 31 percent less likely to get the sexually transmitted disease than those who didn’t, and quotes Michael Russell, professor emeritus of microbiology and immunology in the Jacobs School of Medicine and Biomedical Sciences. "What we found in our studies is that N. gonorrhoeae has the capacity to suppress the development of an immune response against it. This gives us an entirely new way of looking at the infection," he said.
Read more:
http://www.cnbc.com/2017/07/25/a-new-vaccine-to-fight-americas-hidden-health-crisis-gonorrhea.html
Media Relations (University Communications)
330 Crofts Hall (North Campus)
Buffalo, NY 14260-7015
Tel: 716-645-6969
ub-news@buffalo.edu